Tengfeng Yan

564 total citations
31 papers, 375 citations indexed

About

Tengfeng Yan is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Tengfeng Yan has authored 31 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Neurology and 5 papers in Genetics. Recurrent topics in Tengfeng Yan's work include Intracranial Aneurysms: Treatment and Complications (6 papers), Traumatic Brain Injury and Neurovascular Disturbances (6 papers) and Glioma Diagnosis and Treatment (5 papers). Tengfeng Yan is often cited by papers focused on Intracranial Aneurysms: Treatment and Complications (6 papers), Traumatic Brain Injury and Neurovascular Disturbances (6 papers) and Glioma Diagnosis and Treatment (5 papers). Tengfeng Yan collaborates with scholars based in China, Australia and United States. Tengfeng Yan's co-authors include Xingen Zhu, Qianxue Chen, Qing Hu, Miaojing Wu, Shigang Lv, Yuan Jiang, Junhui Chen, Yanghua Fan, Mingchang Li and Lixiang Yang and has published in prestigious journals such as Biomaterials, Brain Research and Journal of neurosurgery.

In The Last Decade

Tengfeng Yan

29 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tengfeng Yan China 11 228 156 72 47 38 31 375
Songshan Chai China 10 139 0.6× 107 0.7× 63 0.9× 48 1.0× 37 1.0× 36 333
Zijun Huo China 11 177 0.8× 65 0.4× 79 1.1× 68 1.4× 23 0.6× 26 350
Aierpati Maimaiti China 10 121 0.5× 85 0.5× 44 0.6× 87 1.9× 28 0.7× 30 265
Xinke Xu China 12 280 1.2× 227 1.5× 27 0.4× 64 1.4× 22 0.6× 23 430
Qungen Xiao China 13 193 0.8× 81 0.5× 46 0.6× 40 0.9× 46 1.2× 23 375
Liguo Ye China 13 141 0.6× 114 0.7× 50 0.7× 124 2.6× 25 0.7× 27 331
Yaru Su China 10 253 1.1× 115 0.7× 16 0.2× 31 0.7× 52 1.4× 19 387
Deheng Li China 11 223 1.0× 186 1.2× 17 0.2× 43 0.9× 35 0.9× 24 335
Soheil Zorofchian United States 8 114 0.5× 79 0.5× 71 1.0× 97 2.1× 23 0.6× 10 336
Zita Reisz Hungary 9 98 0.4× 63 0.4× 45 0.6× 61 1.3× 67 1.8× 35 293

Countries citing papers authored by Tengfeng Yan

Since Specialization
Citations

This map shows the geographic impact of Tengfeng Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tengfeng Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tengfeng Yan more than expected).

Fields of papers citing papers by Tengfeng Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tengfeng Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tengfeng Yan. The network helps show where Tengfeng Yan may publish in the future.

Co-authorship network of co-authors of Tengfeng Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Tengfeng Yan. A scholar is included among the top collaborators of Tengfeng Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tengfeng Yan. Tengfeng Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Qinghua, Fang Li, Tengfeng Yan, et al.. (2025). Puerarin mitigates cognitive decline and white matter injury via CD36-Mediated microglial phagocytosis in chronic cerebral hypoperfusion. Phytomedicine. 138. 156396–156396. 1 indexed citations
2.
3.
Chen, Zhihao, Mingyu Liang, Si Zhang, et al.. (2025). Flavonoids serve as a promising therapeutic agent for ischemic stroke. Brain Research. 1853. 149528–149528. 1 indexed citations
4.
Shu, Lei, Tengfeng Yan, Bing Xiao, et al.. (2025). Development and Validation of Machine Learning Models for Outcome Prediction in Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage Following Endovascular Treatment. Therapeutics and Clinical Risk Management. Volume 21. 293–307. 1 indexed citations
5.
Shu, Lei, Hua Yan, Tengfeng Yan, et al.. (2024). Explainable machine learning in outcome prediction of high-grade aneurysmal subarachnoid hemorrhage. Aging. 16(5). 4654–4669. 10 indexed citations
6.
Yan, Tengfeng, Ping Hu, Minhua Ye, et al.. (2024). ZNF384 transcriptionally activated MGST1 to confer TMZ resistance of glioma cells by negatively regulating ferroptosis. Cancer Chemotherapy and Pharmacology. 94(3). 323–336. 2 indexed citations
7.
Yan, Tengfeng, Zhihao Chen, Yang Xu, et al.. (2024). β-Ketoenamine covalent organic framework nanoplatform combined with immune checkpoint blockade via photodynamic immunotherapy inhibit glioblastoma progression. Bioactive Materials. 44. 531–543. 5 indexed citations
8.
Hu, Ping, Tengfeng Yan, Lei Shu, et al.. (2024). Deep learning-assisted detection and segmentation of intracranial hemorrhage in noncontrast computed tomography scans of acute stroke patients: a systematic review and meta-analysis. International Journal of Surgery. 110(6). 3839–3847. 10 indexed citations
10.
Yan, Tengfeng, et al.. (2023). Claudin-3 facilitates the progression and mediates the tumorigenic effects of TGF-β in glioblastoma multiforme. Medical Oncology. 40(9). 268–268. 8 indexed citations
11.
Wang, Yixuan, Yuntao Li, Qian Sun, et al.. (2022). BCAS3 accelerates glioblastoma tumorigenesis by restraining the P53/GADD45α signaling pathway. Experimental Cell Research. 417(2). 113231–113231. 4 indexed citations
12.
Yan, Tengfeng, et al.. (2022). Identification of Immunogenic Cell Death-Related Signature for Glioma to Predict Survival and Response to Immunotherapy. Cancers. 14(22). 5665–5665. 3 indexed citations
13.
Hu, Ping, Yangfan Liu, Yuntao Li, et al.. (2022). A Comparison of LASSO Regression and Tree-Based Models for Delayed Cerebral Ischemia in Elderly Patients With Subarachnoid Hemorrhage. Frontiers in Neurology. 13. 791547–791547. 11 indexed citations
14.
Ye, Zhang, Lun Gao, Jiayang Cai, et al.. (2022). Esterase-responsive and size-optimized prodrug nanoparticles for effective intracranial drug delivery and glioblastoma treatment. Nanomedicine Nanotechnology Biology and Medicine. 44. 102581–102581. 9 indexed citations
15.
Yan, Tengfeng, Daofeng Tian, Junhui Chen, et al.. (2022). FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma. Frontiers in Oncology. 11. 769033–769033. 16 indexed citations
16.
Cai, Jiayang, Lun Gao, Yixuan Wang, et al.. (2022). TMBIM1 promotes proliferation and attenuates apoptosis in glioblastoma cells by targeting the p38 MAPK signalling pathway. Translational Oncology. 19. 101391–101391. 8 indexed citations
17.
Pu, Bei, Xu Zhang, Tengfeng Yan, et al.. (2021). MICAL2 Promotes Proliferation and Migration of Glioblastoma Cells Through TGF-β/p-Smad2/EMT-Like Signaling Pathway. Frontiers in Oncology. 11. 735180–735180. 13 indexed citations
18.
Jiang, Yuan, Wei Tu, Fang Hua, et al.. (2018). Exosomes secreted by HUVECs attenuate hypoxia/reoxygenation-induced apoptosis in neural cells by suppressing miR-21-3p.. PubMed Central. 10(11). 3529–3541. 33 indexed citations
19.
Yan, Tengfeng, Miaojing Wu, Bing Xiao, et al.. (2018). Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo. Pathology - Research and Practice. 214(11). 1818–1824. 14 indexed citations
20.
Fan, Yanghua, Tengfeng Yan, Yi Chai, Yuan Jiang, & Xingen Zhu. (2017). Long noncoding RNA HOTTIP as an independent prognostic marker in cancer. Clinica Chimica Acta. 482. 224–230. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026